Business Context and Reporting Period
Company: Institutional Financial Markets, Inc. (IFMI)
Filing Type: Form 8-K (Current Report)
Date of Report: May 9, 2013
Summary: The Company entered into a series of material definitive agreements to raise capital, restructure its board of directors, and implement a poison pill plan to protect net operating loss carryforwards. The transactions involve significant equity and debt issuances to Mead Park Capital Partners LLC and Cohen Bros. Financial, LLC.
Key Financial Metrics and Transaction Terms
Capital Raise (Mead Park Transaction):
- Equity: 1,949,167 shares of Common Stock at $2.00/share (Total: $3,898,334).
- Debt: Convertible Senior Promissory Note with principal of $5,847,501.
- Note Terms: 8% annual interest (payable quarterly or PIK); 5-year maturity; convertible at $3.00/share.
Capital Raise (Cohen Transaction):
- Equity: 800,000 shares of Common Stock at $2.00/share (Total: $1,600,000).
- Debt: Convertible Senior Promissory Note with principal of $2,400,000.
- Note Terms: Substantially identical to the Mead Park Note.
Total Consideration: Approximately $13.7 million in aggregate purchase price ($5.5M equity + $8.2M debt).
Liquidity and Debt: The filing does not provide current cash balances or total debt levels. The new notes rank senior to all future indebtedness and pari passu with existing senior obligations.
Material Changes and Governance Restructuring
Board Composition Changes:
- Jack DiMaio (CEO of Mead Park Management) and Christopher Ricciardi (former President) to be nominated for election to the Board.
- Jack DiMaio to be appointed Chairman of the Board.
- Daniel G. Cohen (current Chairman/CEO) to be appointed Vice-Chairman and President of European Operations.
- Board Rights: Mead Park may designate 2 directors if ownership is ≥15%, or 1 director if ownership is ≥10% but <15%.
Executive Compensation Changes:
- Daniel G. Cohen entered an Amended and Restated Employment Agreement.
- Guaranteed Payment: Minimum $600,000 annually.
- Allocations: 25% of European Business net income (capped at $5M) and 20% of gross revenues from non-European broker-dealer transactions he generates.
- Severance: Up to $3,000,000 single-sum payment plus accrued benefits in the event of termination without Cause or Good Reason.
Preferred Stock Exchange: Cohen Bros. Financial exchanged 4,983,557 Series D Preferred Shares for Series E Preferred Shares. This removed a restriction preventing Cohen from redeeming his IFMI Units until December 31, 2013.
Guidance, Risks, and Contingencies
Section 382 Rights Plan (Poison Pill):
- Purpose: To prevent an "Ownership Change" that would limit the Company's ability to use net operating loss and net capital loss carryforwards (deferred tax assets).
- Trigger: Any person acquiring 4.95% or more of Common Stock (Acquiring Person).
- Flip-In: Upon a triggering event, rights holders (excluding the Acquiring Person) can purchase stock worth 2x the exercise price ($100) for $100.
- Expiration: October 1, 2016, or earlier upon redemption or repeal of Section 382.
Conditions Precedent to Closing:
- NYSE MKT listing approval.
- Stockholder approval of share issuances.
- Completion of the Cohen Purchase Agreement.
- Specific Board composition changes.
Risks: The filing highlights risks regarding the consummation of transactions, liquidity, general economic conditions, and the potential limitation of tax assets if an ownership change occurs.
Investor Verification Checklist
- Closing Status: Verify if the transactions closed in Q3 2013 as anticipated or if they were terminated.
- Stockholder Approval: Confirm the outcome of the 2013 annual meeting regarding the issuance of shares and election of new directors.
- Board Composition: Verify the final composition of the Board of Directors and the appointment of Jack DiMaio as Chairman.
- Debt Service: Monitor the Company's ability to service the new $8.2M in convertible debt, particularly if dividends are not paid (triggering PIK interest).
- Tax Asset Utilization: Assess whether the Section 382 Rights Plan successfully preserved the value of the Company's deferred tax assets.
- Executive Retention: Confirm Daniel G. Cohen's continued role and compensation structure under the new agreement.